id | C00000207 |
---|---|
Name | Benzoic acid |
CAS RN | 65-85-0 |
Standard InChI | InChI=1S/C7H6O2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H,8,9) |
Standard InChI (Main Layer) | InChI=1S/C7H6O2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H,8,9) |
Phytochemical cluster | |
---|---|
KCF-S cluster | No. 2192 |
By standard InChI | CHEMBL541 |
---|---|
By standard InChI Main Layer | CHEMBL541 |
By LinkDB | C00180 |
---|
By CAS RN | D019817 |
---|
class name | count |
---|---|
rosids | 11 |
eudicotyledons | 5 |
Liliopsida | 4 |
asterids | 4 |
Magnoliophyta | 3 |
Euphyllophyta | 1 |
Spermatophyta | 1 |
family name | count |
---|---|
Fabaceae | 5 |
Paeoniaceae | 4 |
Asteraceae | 2 |
Brassicaceae | 2 |
Annonaceae | 2 |
Rutaceae | 1 |
Asparagaceae | 1 |
Colchicaceae | 1 |
Petiveriaceae | 1 |
Apocynaceae | 1 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL541 |
CHEMBL1909136
(2)
|
1 / 0 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | CHEMBL541 |
CHEMBL2077868
(1)
|
0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | CHEMBL541 |
CHEMBL1909139
(2)
|
0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | CHEMBL541 |
CHEMBL1909131
(2)
|
0 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | CHEMBL541 |
CHEMBL1909190
(2)
|
2 / 2 |
P08246 | Neutrophil elastase | S1A | CHEMBL541 |
CHEMBL1909195
(2)
|
2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | CHEMBL541 |
CHEMBL1909215
(2)
|
0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | CHEMBL541 |
CHEMBL1909201
(2)
|
0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | CHEMBL541 |
CHEMBL1909176
(2)
|
0 / 0 |
P29466 | Caspase-1 | C14 | CHEMBL541 |
CHEMBL1909193
(2)
|
0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | CHEMBL541 |
CHEMBL1909198
(2)
|
0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | CHEMBL541 |
CHEMBL1909199
(2)
|
0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | CHEMBL541 |
CHEMBL1909197
(2)
|
2 / 2 |
Q99489 | D-aspartate oxidase | Enzyme | CHEMBL541 |
CHEMBL2327933
(1)
|
0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | CHEMBL541 |
CHEMBL1614281
(1)
CHEMBL1614361
(1)
|
3 / 2 |
P00918 | Carbonic anhydrase 2 | Lyase | CHEMBL541 |
CHEMBL1909123
(2)
|
1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | CHEMBL541 |
CHEMBL1909092
(2)
|
0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | CHEMBL541 |
CHEMBL1909169
(2)
|
1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | CHEMBL541 |
CHEMBL1909157
(2)
|
0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | CHEMBL541 |
CHEMBL1909156
(2)
|
0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | CHEMBL541 |
CHEMBL1909143
(2)
|
1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | CHEMBL541 |
CHEMBL1909174
(2)
|
0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | CHEMBL541 |
CHEMBL1909090
(2)
|
0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | CHEMBL541 |
CHEMBL1909093
(2)
|
0 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | CHEMBL541 |
CHEMBL1909127
(2)
|
0 / 0 |
Q9UQ49 | Sialidase-3 | Enzyme | CHEMBL541 |
CHEMBL751097
(1)
|
0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | CHEMBL541 |
CHEMBL1909204
(2)
|
0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | CHEMBL541 |
CHEMBL1909202
(2)
|
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL541 |
CHEMBL1909135
(2)
|
0 / 1 |
P14920 | D-amino-acid oxidase | Enzyme | CHEMBL541 |
CHEMBL2327779
(1)
CHEMBL2327788
(1)
CHEMBL2327791 (1) CHEMBL2327928 (1) CHEMBL2327931 (1) CHEMBL2327932 (2) |
0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | CHEMBL541 |
CHEMBL1909203
(2)
|
1 / 11 |
P14416 | D(2) dopamine receptor | Dopamine receptor | CHEMBL541 |
CHEMBL1909140
(2)
|
2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | CHEMBL541 |
CHEMBL1909130
(2)
|
0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | CHEMBL541 |
CHEMBL1909120
(2)
|
0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | CHEMBL541 |
CHEMBL1909181
(2)
|
0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | CHEMBL541 |
CHEMBL1909164
(2)
|
0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | CHEMBL541 |
CHEMBL1909214
(2)
|
0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | CHEMBL541 |
CHEMBL1909175
(2)
|
0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | CHEMBL541 |
CHEMBL1909096
(2)
|
1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | CHEMBL541 |
CHEMBL1909118
(2)
|
0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | CHEMBL541 |
CHEMBL1909166
(2)
|
1 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | CHEMBL541 |
CHEMBL1909133
(2)
|
0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | CHEMBL541 |
CHEMBL1908086
(1)
|
0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | CHEMBL541 |
CHEMBL1909158
(2)
|
0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | CHEMBL541 |
CHEMBL1909088
(2)
|
0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | CHEMBL541 |
CHEMBL1909142
(2)
|
0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | CHEMBL541 |
CHEMBL1909101
(2)
|
0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | CHEMBL541 |
CHEMBL1909141
(2)
|
1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | CHEMBL541 |
CHEMBL1909180
(2)
|
0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | CHEMBL541 |
CHEMBL1909146
(2)
|
0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | CHEMBL541 |
CHEMBL1909104
(2)
|
0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | CHEMBL541 |
CHEMBL1909144
(2)
|
0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | CHEMBL541 |
CHEMBL1909100
(2)
|
0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | CHEMBL541 |
CHEMBL1909167
(2)
|
1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | CHEMBL541 |
CHEMBL1909129
(2)
|
0 / 0 |
P08311 | Cathepsin G | S1A | CHEMBL541 |
CHEMBL1909194
(2)
|
0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | CHEMBL541 |
CHEMBL1909110
(2)
|
1 / 0 |
P03956 | Interstitial collagenase | M10A | CHEMBL541 |
CHEMBL1909196
(2)
|
0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | CHEMBL541 |
CHEMBL1909119
(2)
|
0 / 0 |
Q9GZT4 | Serine racemase | Enzyme | CHEMBL541 |
CHEMBL2327930
(1)
|
0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | CHEMBL541 |
CHEMBL1909150
(2)
|
0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | CHEMBL541 |
CHEMBL1909171
(2)
|
2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | CHEMBL541 |
CHEMBL1909170
(2)
|
0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | CHEMBL541 |
CHEMBL1909122
(2)
|
0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | CHEMBL541 |
CHEMBL1909109
(2)
|
2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | CHEMBL541 |
CHEMBL1909205
(2)
|
5 / 10 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | CHEMBL541 |
CHEMBL1909172
(2)
|
1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | CHEMBL541 |
CHEMBL1909114
(2)
|
0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | CHEMBL541 |
CHEMBL1909125
(2)
|
0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | CHEMBL541 |
CHEMBL1909126
(2)
|
3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | CHEMBL541 |
CHEMBL1909108
(2)
|
0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | CHEMBL541 |
CHEMBL1909124
(2)
|
1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL541 |
CHEMBL1909200
(2)
|
0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | CHEMBL541 |
CHEMBL1909207
(2)
|
2 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL541 |
CHEMBL1909132
(2)
|
0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | CHEMBL541 |
CHEMBL1909186
(2)
|
0 / 0 |
P03372 | Estrogen receptor | NR3A1 | CHEMBL541 |
CHEMBL1909145
(2)
|
1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | CHEMBL541 |
CHEMBL1909091
(2)
|
1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | CHEMBL541 |
CHEMBL1909212
(2)
|
1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | CHEMBL541 |
CHEMBL1909211
(2)
|
0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | CHEMBL541 |
CHEMBL1909105
(2)
|
0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | CHEMBL541 |
CHEMBL1909182
(2)
|
0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | CHEMBL541 |
CHEMBL1909173
(2)
|
0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | CHEMBL541 |
CHEMBL1909113
(2)
|
0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | CHEMBL541 |
CHEMBL1909187
(2)
|
0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | CHEMBL541 |
CHEMBL1909168
(2)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL541 |
CHEMBL1909134
(2)
|
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL541 |
CHEMBL1909138
(2)
|
0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | CHEMBL541 |
CHEMBL1909137
(2)
|
0 / 0 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | CHEMBL541 |
CHEMBL1908083
(1)
|
0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | CHEMBL541 |
CHEMBL1909094
(2)
|
1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | CHEMBL541 |
CHEMBL1909087
(2)
|
0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | CHEMBL541 |
CHEMBL1909213
(2)
|
0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | CHEMBL541 |
CHEMBL1909089
(2)
|
0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | CHEMBL541 |
CHEMBL1909116
(2)
|
1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | CHEMBL541 |
CHEMBL1909206
(2)
|
0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | CHEMBL541 |
CHEMBL1909128
(2)
|
0 / 0 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
D019817 | 231 |
AKR1B1
ADR ALDR1 ALR2 AR |
aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) | Benzoic Acid results in increased expression of AKR1B1 mRNA |
increases expression
|
mRNA |
20566472
|
D019817 | 57016 |
AKR1B10
AKR1B11 AKR1B12 ALDRLn ARL-1 ARL1 HIS HSI |
aldo-keto reductase family 1, member B10 (aldose reductase) (EC:1.1.1.2) | Benzoic Acid results in increased expression of AKR1B10 mRNA |
increases expression
|
mRNA |
20566472
|
D019817 | 1645 |
AKR1C1
2-ALPHA-HSD 20-ALPHA-HSD C9 DD1 DD1/DD2 DDH DDH1 H-37 HAKRC HBAB MBAB |
aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) | Benzoic Acid results in increased expression of AKR1C1 mRNA |
increases expression
|
mRNA |
20566472
|
D019817 | 8644 |
AKR1C3
DD3 DDX HA1753 HAKRB HAKRe HSD17B5 PGFS hluPGFS |
aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) | Benzoic Acid results in increased expression of AKR1C3 mRNA |
increases expression
|
mRNA |
20566472
|
D019817 | 2235 |
FECH
EPP FCE |
ferrochelatase (EC:4.99.1.1) | Benzoic Acid results in increased expression of FECH mRNA |
increases expression
|
mRNA |
20566472
|
D019817 | 2512 |
FTL
NBIA3 |
ferritin, light polypeptide | Benzoic Acid results in increased expression of FTL mRNA |
increases expression
|
mRNA |
20566472
|
D019817 | 2539 |
G6PD
G6PD1 |
glucose-6-phosphate dehydrogenase (EC:1.1.1.49) | Benzoic Acid results in increased expression of G6PD mRNA |
increases expression
|
mRNA |
20566472
|
D019817 | 2729 |
GCLC
GCL GCS GLCL GLCLC |
glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) | Benzoic Acid results in increased expression of GCLC mRNA |
increases expression
|
mRNA |
20566472
|
D019817 | 2730 |
GCLM
GLCLR |
glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) | Benzoic Acid results in increased expression of GCLM mRNA |
increases expression
|
mRNA |
20566472
|
D019817 | 2936 |
GSR
|
glutathione reductase (EC:1.8.1.7) | Benzoic Acid results in increased expression of GSR mRNA |
increases expression
|
mRNA |
20566472
|
D019817 | 2938 |
GSTA1
GST2 GSTA1-1 GTH1 |
glutathione S-transferase alpha 1 (EC:2.5.1.18) | Benzoic Acid results in increased activity of GSTA1 protein mutant form |
increases activity
|
protein |
10329179
|
D019817 | 3162 |
HMOX1
HMOX1D HO-1 HSP32 bK286B10 |
heme oxygenase (decycling) 1 (EC:1.14.99.3) | Benzoic Acid results in increased expression of HMOX1 mRNA |
increases expression
|
mRNA |
20566472
|
D019817 | 4097 |
MAFG
hMAF |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G | Benzoic Acid results in increased expression of MAFG mRNA |
increases expression
|
mRNA |
20566472
|
D019817 | 4199 |
ME1
HUMNDME MES |
malic enzyme 1, NADP(+)-dependent, cytosolic (EC:1.1.1.40) | Benzoic Acid results in increased expression of ME1 mRNA |
increases expression
|
mRNA |
20566472
|
D019817 | 4489 |
MT1A
MT1 MT1S MTC |
metallothionein 1A | Benzoic Acid results in increased expression of MT1A mRNA |
increases expression
|
mRNA |
20491607
|
D019817 | 4502 |
MT2A
MT2 |
metallothionein 2A | Benzoic Acid results in increased expression of MT2A mRNA |
increases expression
|
mRNA |
20491607
|
D019817 | 4846 |
NOS3
ECNOS eNOS |
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) | Benzoic Acid results in increased expression of NOS3 mRNA |
increases expression
|
mRNA |
15740983
|
D019817 | 1728 |
NQO1
DHQU DIA4 DTD NMOR1 NMORI QR1 |
NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) | Benzoic Acid results in increased expression of NQO1 mRNA |
increases expression
|
mRNA |
20566472
|
D019817 | 5226 |
PGD
6PGD |
phosphogluconate dehydrogenase (EC:1.1.1.44) | Benzoic Acid results in increased expression of PGD mRNA |
increases expression
|
mRNA |
20566472
|
D019817 | 22949 |
PTGR1
LTB4DH PGR1 ZADH3 |
prostaglandin reductase 1 (EC:1.3.1.48 1.3.1.74) | Benzoic Acid results in increased expression of PTGR1 mRNA |
increases expression
|
mRNA |
20566472
|
D019817 | 6566 |
SLC16A1
HHF7 MCT MCT1 |
solute carrier family 16 (monocarboxylate transporter), member 1 | morin inhibits the reaction [SLC16A1 protein results in increased uptake of Benzoic Acid] |
decreases reaction
/ increases uptake |
protein |
17976262
|
D019817 | 6566 |
SLC16A1
HHF7 MCT MCT1 |
solute carrier family 16 (monocarboxylate transporter), member 1 | naringenin inhibits the reaction [SLC16A1 protein results in increased uptake of Benzoic Acid] |
decreases reaction
/ increases uptake |
protein |
17976262
|
D019817 | 6566 |
SLC16A1
HHF7 MCT MCT1 |
solute carrier family 16 (monocarboxylate transporter), member 1 | Quercetin inhibits the reaction [SLC16A1 protein results in increased uptake of Benzoic Acid] |
decreases reaction
/ increases uptake |
protein |
17976262
|
D019817 | 6566 |
SLC16A1
HHF7 MCT MCT1 |
solute carrier family 16 (monocarboxylate transporter), member 1 | silybin inhibits the reaction [SLC16A1 protein results in increased uptake of Benzoic Acid] |
decreases reaction
/ increases uptake |
protein |
17976262
|
D019817 | 6566 |
SLC16A1
HHF7 MCT MCT1 |
solute carrier family 16 (monocarboxylate transporter), member 1 | SLC16A1 protein results in increased uptake of Benzoic Acid |
increases uptake
|
protein |
17976262
|
D019817 | 140809 |
SRXN1
C20orf139 Npn3 SRX SRX1 |
sulfiredoxin 1 (EC:1.8.98.2) | Benzoic Acid results in increased expression of SRXN1 mRNA |
increases expression
|
mRNA |
20566472
|
D019817 | 7295 |
TXN
TRDX TRX TRX1 |
thioredoxin | Benzoic Acid results in increased expression of TXN mRNA |
increases expression
|
mRNA |
20491607
|
D019817 | 7296 |
TXNRD1
GRIM-12 TR TR1 TRXR1 TXNR |
thioredoxin reductase 1 (EC:1.8.1.9) | Benzoic Acid results in increased expression of TXNRD1 mRNA |
increases expression
|
mRNA |
20566472
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#615363 | Estrogen resistance; estrr |
P03372
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 |
#608516 | Major depressive disorder; mdd |
P08172
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#607276 | Resting heart rate, variation in |
P08588
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | disease name | UniProt |
---|---|---|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
|
H00027 | Ovarian cancer |
P04626
(related)
|
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|